Hologic, J&J Unit Strike $12.5M Deal In Biopsy IP War

By Brendan Pierson

Law360, New York (February 19, 2010, 6:07 PM ET) -- Medical device company Hologic Inc. has agreed to pay $12.5 million to end a long-running patent battle with Johnson & Johnson unit Ethicon Endo-Surgery Inc., putting to rest three lawsuits over biopsy products.

Under the deal, which the companies announced Friday, Hologic will also pay Ethicon ongoing royalties on sales of its Atec and Eviva biopsy products, and Ethicon will pay Hologic ongoing royalties on sales of its Mammotome MR biopsy product.

Neither party has admitted liability, and each will bear its own litigation costs, according...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles